Pharma Force Listed by hunters Ransomware Group: Ransomware Claim — What’s Alleged & What To Do
Pharma Force was listed by the Hunters ransomware group on April 21, 2025, after internal files were exfiltrated in a ransomware attack. Individuals who may have shared data with the organization should review any notices they receive and consider protective steps such as monitoring accounts and changing passwords.
Ransomware groups continue to target organisations that hold sensitive operational and personal data, using leak-site listings to pressure victims even when encryption is not confirmed. Against that backdrop, Pharma Force was publicly listed by the hunters ransomware group on 21 April 2025. Public reporting indicates that internal files were claimed to have been exfiltrated, while encryption of systems was not reported. The number of people affected remains unknown, and many operational details have not been disclosed. For anyone whose information may have been held by the company, the listing raises concrete questions about what was taken and how it might be misused.
This article sets out only what has been reported, places the claim in context, and outlines practical steps for those who may be affected. No assumption is made that the listing has been independently verified or that the organisation was at fault.
Breaking down the breach
According to the available record, Pharma Force was listed by the hunters ransomware group on 21 April 2025. The reported summary states that data was exfiltrated and that systems were not encrypted. The data types named are internal files taken in a ransomware attack. No figure has been given for the number of people affected, and no further technical details—such as the initial access method, the volume of data, the precise date of intrusion, or confirmation of the claim—have been made public. The listing itself is a claim by the group; independent verification of the breach or of the contents of any stolen material has not been reported in the facts provided.
In short, the public picture is limited to the date of the listing, the organisation named, the assertion that internal files were removed, and the statement that encryption did not occur. Everything else remains undisclosed.
The group behind it: hunters
Hunters is a ransomware operation that has appeared on public leak sites used by such groups. Like other actors in this space, it typically claims to have stolen data from victims and threatens to publish or sell that material unless a ransom is paid. Public reporting on the group has described the familiar double-extortion pattern—data theft followed by pressure—though individual incidents vary. In this case the facts state that encryption was not reported, so the listing rests on the claim of exfiltration alone.
No statements attributed specifically to hunters about Pharma Force beyond the listing itself appear in the available record. Therefore the group’s claim that internal files were taken should be treated as an unverified assertion until corroborated by the organisation or by independent investigation. Prior activity by hunters against other organisations is a matter of public record in the broader threat landscape, but those earlier incidents do not establish what occurred here.
About Pharma Force
Pharma Force operates in the pharmaceutical sector. Organisations of this type typically manage research data, manufacturing records, supply-chain information, employee details, and sometimes patient or clinical-trial related material. Even when a company is not a direct healthcare provider, the data it holds can include commercially sensitive intellectual property and personally identifiable information about staff, partners, or trial participants.
A breach claim against such an organisation is consequential because pharmaceutical data can be valuable both for competitive intelligence and for identity-related fraud. The exact nature of Pharma Force’s holdings and the sensitivity of any particular files remain unconfirmed; public detail on the company’s size, locations, or specific data practices is limited in the facts supplied.
What was likely exposed
The facts name only “internal files” as having been exfiltrated. No inventory of file types, no count of records, and no confirmation of personal data categories have been disclosed. Organisations in the pharmaceutical sector commonly store employee records, vendor contracts, research documents, regulatory correspondence, and operational databases. Any of these could, in principle, appear among internal files, but that is a general observation about the sector, not a statement of what was taken in this incident.
Because the precise contents are unconfirmed, it is not possible to state as fact that names, addresses, financial details, health information, or intellectual property were among the material. Readers should treat any such specifics as unknown until the organisation or a verified source provides them.
Why it matters
For individuals whose data may have been held by Pharma Force, the practical risks include identity theft, targeted phishing, and the long-term circulation of personal details on criminal markets. Even limited internal files can contain enough identifiers to enable fraud or social-engineering attacks. For the organisation, the listing creates reputational pressure, potential regulatory scrutiny, and the operational cost of investigation and notification—regardless of whether a ransom is paid.
Because the number of people affected is unknown and encryption was not reported, the immediate disruption to day-to-day systems may have been lower than in classic ransomware cases; the longer-term exposure of any stolen files remains the central concern. The absence of Reported Details does not eliminate risk; it simply means affected parties must proceed on the basis of caution rather than certainty.
What to do if you're exposed
If you have a past or present relationship with Pharma Force—as an employee, contractor, partner, or participant in any programme—monitor financial and email accounts for unusual activity. Enable multi-factor authentication where available, and treat unsolicited messages that reference the company or the breach with scepticism. Consider placing fraud alerts with credit bureaus if you believe personal identifiers may have been involved. Keep records of any official notifications you receive from the organisation.
You can also run a free exposure scan of your email address to check whether it has already appeared in known breach data sets. That step will not confirm or rule out involvement in this specific incident, but it can surface other exposures that warrant attention. Stay alert for further official statements; until more verified information is released, treat the hunters listing as a claim rather than established fact.
AICompiled with AI assistance from public sources and published under our editorial standards.
How this breach connects
More recent breaches
Digestive Specialists Listed by hunters Ransomware GroupCourageous Home Care Listed by hunters Ransomware GroupWrap & Send Services Listed by hunters Ransomware GroupCorantioquia Listed by hunters Ransomware GroupLatest breaches
Read GalaxyWarden’s full analysis of the Pharma Force Listed by hunters Ransomware Group →
Publicly posted by hunters — unverified claim, pending independent verification
Breach listings — particularly those originating from ransomware or leak sites — are third-party claims that may be unverified, incomplete, or inaccurate. A listing does not by itself confirm that a breach occurred or that any specific data was exposed. Severity is an automated assessment, not a definitive rating. Verification status is shown where available.
Attributions to threat groups and methods reflect public reporting and, in some cases, unverified claims made by the groups themselves; they may be incomplete or later revised. Recent Breaches and GalaxyWarden are independent and are not affiliated with, and do not endorse, any company or group named on this page. This information is aggregated from public sources for awareness only and is not legal, security, or investment advice.